BioMarin, Sarah Cannon Research UK Expand PARP Inhibitor Trial Outside US


IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More


RXi Initiates Third Phase IIa Trial of Anti-scarring Drug


Duke Team Uncovers RNAi-based Drug-resistance Mechanism in Pathogenic Fungus


Illumina Continues Push into Oncology, Reproductive Health; Fine Tunes its 'Clinical Readiness' Strategy


Survey Highlights Successes and Challenges for Early Adopters of Clinical NGS


Sequenom Runs Nearly 41K MaterniT21 Tests; Reports Mixed Progress on Reimbursement


Recent Clinical Sequencing Papers of Note


People in the News: Greg Lucier, Vicky Gregg, Franz Och, Matt Brunner, More


New Products: Foundation Medicine's FoundationOne; Vitalité Health's Cancer Panel